Giselle S Mosnaim
Overview
Explore the profile of Giselle S Mosnaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarava A, Marshall C, Reichert D, Ye A, Khanal P, Robbins S, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e200.
PMID: 39655012
Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was...
2.
Park H, Yin A, Barranta C, Lee J, Caputo C, Sachithanandham J, et al.
JCI Insight
. 2024 Mar;
9(8.
PMID: 38483534
BACKGROUNDCOVID-19 convalescent plasma (CCP) virus-specific antibody levels that translate into recipient posttransfusion antibody levels sufficient to prevent disease progression are not defined.METHODSThis secondary analysis correlated donor and recipient antibody levels...
3.
Conway A, Lieberman J, Codispoti C, Mahdavinia M, Anagnostou A, Blatman K, et al.
J Allergy Clin Immunol Pract
. 2024 Mar;
12(5):1170-1180.
PMID: 38458435
Pharmacoequity refers to equity in access to pharmacotherapy for all patients and is an especially large barrier to biologic agents in patients with allergic diseases. Value-based care models can prompt...
4.
Bracken A, Oppenheimer J, Mosnaim G, Rank M
Ann Allergy Asthma Immunol
. 2024 Jan;
132(5):561-563.
PMID: 38253123
No abstract available.
5.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Dec;
15(1):e0297923.
PMID: 38095433
No abstract available.
6.
Mosnaim G, Hoyte F, Safioti G, Brown R, Hill T, Li T, et al.
J Allergy Clin Immunol Pract
. 2023 Dec;
12(2):385-395.e4.
PMID: 38040117
Background: Digital health tools have been shown to help address challenges in asthma control, including inhaler technique, treatment adherence, and short-acting β-agonist overuse. The maintenance and reliever Digihaler System (DS)...
7.
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Habtehyimer F, Zhu X, Redd A, Gebo K, Abraham A, Patel E, et al.
Microbiol Spectr
. 2023 Nov;
12(1):e0328623.
PMID: 38009954
This study examined the role that cytokines may have played in the beneficial outcomes found when outpatient individuals infected with SARS-CoV-2 were transfused with COVID-19 convalescent plasma (CCP) early in...
8.
Ho J, Shaker M, Greenhawt M, Sadatsafavi M, Abrams E, Oppenheimer J, et al.
Ann Allergy Asthma Immunol
. 2023 Oct;
132(2):229-239.e3.
PMID: 37879568
Background: The management of mild asthma has lacked an over-the-counter (OTC) option aside from inhaled epinephrine, which is available in the United States. However, inhaled epinephrine use without an inhaled...
9.
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Sep;
14(5):e0061823.
PMID: 37724870
Approximately 20% of individuals infected with SARS-CoV-2 experienced long-term health effects, as defined PCC. However, it is unknown if there are any early biomarkers associated with PCC or whether early...
10.
Zhu X, Gebo K, Abraham A, Habtehyimer F, Patel E, Laeyendecker O, et al.
Lancet Microbe
. 2023 Sep;
4(9):e692-e703.
PMID: 37659419
Background: Cytokines and chemokines play a critical role in the response to infection and vaccination. We aimed to assess the longitudinal association of COVID-19 vaccination with cytokine and chemokine concentrations...